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Abstract. Fowlpox virus (FWPV) has been used as a recombinant vaccine vector to express antigens 
from several important avian pathogens. Attempts have been made to improve vaccine strains induced-
host immune responses by coexpressing cytokines. This study describes the construction of recombinant 
FWPV (rFWPV) strain FP9 and immunological responses in specific-pathogen-free (SPF) chickens, co-
expressing avian influenza virus (AIV) H5 of A/Chicken/Malaysia/5858/2004, and chicken IL-15 
cytokine genes. Expression of H5 (50 kD) was confirmed by western blotting. Anti-H5 antibodies, which 
were measured by the haemagglutinin inhibition test, were at the highest levels at Week 3 post-inoculation 
in both rFWPV/H5- and rFWPV/H5/IL-15-vaccinated chickens, but decreased to undetectable levels 
from Week 5 onwards. CD3+/CD4+ or CD3+/CD8+T cell populations, assessed using flow cytometry, 
were significantly increased in both WT FP9- and rFWPV/H5-vaccinated chickens and were also higher 
than in rFWPV/H5/IL-15- vaccinated chickens, at Week 2. Gene expression analysis using real time 
quantitative polymerase chain reaction (qPCR) demonstrated upregulation of IL-15 expression in all 
vaccinated groups with rFWPV/H5/IL-15 having the highest fold change, at day 2 (117±51.53). Despite 
showing upregulation, fold change values of the IL-18 expression were below 1.00 for all vaccinated 
groups at day 2, 4 and 6. This study shows successful construction of rFWPV/H5 co-expressing IL-15, 
with modified immunogenicity upon inoculation into SPF chickens. 
 




Since the late 1980s, recombinant FWPVs 
(rFWPV)s based on attenuated FWPV strains 
have been developed to express antigens from 
several important avian pathogens, including: 
avian influenza virus (AIV; (Qian et al., 2012)), 
Newcastle disease virus (NDV; (Sun et al., 2008) 
and Marek’s disease virus (MDV; (Lee et al., 2003). 
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rFWPVs expressing haemagglutinin (HA) H5 
protein of AIV (rFWPV/H5), particularly derived 
from A/Turkey/Ireland/83 (H5N9), or 
A/Goose/Guangdong/96 (H5N1), have been 
used in South East Asia as vaccines against highly 
pathogenic avian influenza (HPAI) H5N1. 
Despite this preventive measure, HPAI H5N1 is 
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still a major concern due to its ongoing, sporadic 
re-emergence. The need to boost existing 
eradication efforts to limit the spread and 
occurrence of the outbreak has prompted 
development of several strategies to improve 
readily available avian influenza vaccines. We 
describe here one such strategy: to co-express 
host cytokines from rFWPV/H5. 
In mice, recombinant vaccinia virus (rVACV) 
co-expressing gp160 of human immunodeficiency 
virus (HIV) and human interleukin 15 (hIL-15) 
has been shown to provide a stronger and more 
enduring response than rVACV expressing gp160 
alone (Oh et al., 2003). Integration of hIL-15 into 
rVACV Wyeth strain or Modified VACV Ankara 
(MVA) resulted in better survival (Perera et al., 
2007) and enhanced in vivo viral clearance 
(Zielinski et al., 2010) in vaccinated athymic nude 
mice upon intranasal challenge with virulent 
VACV strain Western Reserve, or intravenous 
challenge with monkeypox virus strain Zaire 79, 
respectively. Enhanced CD4 and CD8 T cell 
memory responses, along with reduction in lung 
mycobacterial load in lungs, was also observed in 
mice infected with Bacille Calmette-Guérin 
(BCG), supplemented with IL-7 and IL-15 
recombinant proteins, but not IL-1, IL-6 or 
interferon (IFN)-α (Singh et al., 2010). In mice 
model, it has also been shown that IL-15 offers 
potent antiviral effects against rVACV 
coexpressing IL-15, with high dependency on the 
presence of NK cells and IFNs (Foong et al., 
2009). 
Almost all of the chicken cytokines that have 
been investigated are Th1-like. In a rare avian 
study, in ovo plasmid DNA vaccination against an 
intestinal coccidial parasite, Eimeria acervulina, 
using coccidial gene 3-1E coexpressed with 
chicken IL-15, was shown to induce higher serum 
antibody levels than immunization with 3-1E 
alone. Following challenge with the homologous 
parasite, chickens vaccinated with 3-1E plus IL-
15 showed a significant decreased in oocyst 
shedding and had an increased body weight, 
compared to chickens vaccinated with 3-1E alone 
(Lillehoj et al., 2005). Similar results were obtained 
whether the construct was given subcutaneously 
(Min et al., 2001) or intramuscularly (Ma et al., 
2013). 
Studies with rFWPV coexpressing HA from 
AIV H5N1 and chicken IL-18 (Chen et al., 2011; 
Mingxiao et al., 2006) or IL-6 (Qian et al., 2012) 
have been described. The results showed that all 
chickens vaccinated with rFWPV/H5/IL-18 
exhibited reduced virus shedding and replication 
(Chen et al., 2011), and had higher levels of cellular 
immunity (Mingxiao et al., 2006), compared to 
rFWPV/H5 alone. Study of the effect of chIL-15 
coexpression by rFWPV/H5 in chickens, as 
reported here, is novel. 
 
 
MATERIALS AND METHODS 
 
 
Ethical approval. All animal experiments 
performed in this study were in accordance with 
the ethical standards of the local Institutional 
Animal Care and Use Committee (IACUC) of 
Universiti Putra Malaysia (UPM) with reference 
number UPM/FPV/PS/3.2.1.551/AUP-R72. 
 
Viruses and cells. The initial stock of parental 
FP9 was from M.A. Skinner laboratory (Imperial 
College London, UK). The development of FP9 
via 438 serial passages of the wild-type fowlpox 
virus HP-1, followed by plaque purification, has 
been described (Laidlaw and Skinner, 2004). 
Chicken embryonic fibroblast (CEFs) used in this 
study were cultured in 2% newborn bovine serum 
(NBBS) in DMEM media (both from Gibco).  
 
Construction of recombinant plasmids. 
Previously cloned and sequenced cDNA 
encoding full-length H5 of influenza strain 
A/Ch/Malaysia/5744/2004 (Balasubramaniam et 
al., 2011) was amplified by PCR with primers H5-
F: 5’-ATCGGATATCATGGAGAAAATAGTG 
C-3’ and H5-R: 5’-GACTGATATCTTAAA 
TGCAAATTCTGC-3’, introducing EcoRV sites 
as underlined. Sequence encoding the pentabasic 
peptide motif at the protease cleavage site of H5 
was replaced with threonine (T) using mutagenic 
primers S(2-F): 5’-CAAAGAGAGACAAGAGG 
ATTATTTGGAGCTATAG-3’ and S(1-R): 5’-
CAAATAATCCTCTTGTCTCTCTTTGAGG
GCTATTTC-3’. 
The assembled amplicon was inserted into the 
SmaI site of lac Z-selectable, FWPV 
expression/recombination vector pEFL29 
(Qingzhong et al., 1994), downstream of a copy of 
the vaccinia virus p7.5 early/late promoter. The 
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chicken IL-15 gene (supplied by the late Prof. Dr. 
Pete Kaiser from the then Institute for Animal 
Health, Compton, UK) was inserted downstream 
of a synthetic/hybrid promoter in vector 
pEFgpt12S, before being subcloned into vector 
pPC1.X (Abd Razak, 2011). Positive 
transformants were grown in LB broth (15 mL) 
supplemented with appropriate antibiotic(s) (750 
µg) at 37°C overnight. The culture (0.5 µL) was 
used to provide templates for analytical PCR. The 
reaction mixture for a small scale PCR verification 
contained 10X PCR buffer (2 µL; Sigma), 
JumpStart Taq DNA polymerase (0.5 U; Sigma), 
dNTPs (0.5 µL of 10 mM) and oligonucleotide 
primers (0.5 µL of each 10 µM stock), in a total 
volume of 20 µL. PCR was conducted in 2 steps; 
4 cycles of 95°C for 3 min, 95°C for 30 s, 50°C 
for 30 s, and 72°C for 1.5 min followed by 26 
cycles of 95°C for 30 s, 59°C for 30 s, and 7°C for 
1.5 min. Final extension was operated at 72°C for 
10 minutes. Verification of H5 integration into 
FWPV was carried out using H5-F and H5-R 
primers, while primers pPC1.X-F: 5’-
ATGAAAAATAGTACCACTATGG-3’ and IL-
15R: 5’-ACAGAGTTTTGTAAAGGTTATACA 
GAGG-3’ were used to screen for rFWPV/H5 
carrying IL-15 gene. 
 
Recombination/transfection, selection and 
purification of recombinant viruses. The 
detailed protocol for recombination/transfection 
has been described (Laidlaw and Skinner, 2014), 
with minor modifications i.e. replacing 199 media 
with DMEM (Gibco), and polyfect with lipofectin 
(Thermo Fisher Scientific), of the same volume. 
Successful recovery of rFWPV/H5 carrying a 
LacZ gene from pEFL29 into FP9 was 
demonstrated by blue plaques upon X-Gal 
overlay (at final concentration of 0.4 mg/mL) on 
day 4 post-transfection. Further screening for 
rFWPV/H5 carrying chIL-15 was done by 
mycophenolic acid (MPA) selection of gpt gene 
and spontaneous resolving of the gpt gene by a 
second crossover event, as described previously 
(Laidlaw et al., 1998). The recombinant protein 
lysates were prepared by infecting CEFs, with 
rFWPV/H5 at a multiplicity of infection (MOI) 
of 3, for 48 hours. The cell pellet was subjected to 
15% SDS-PAGE. The electro-transferred 
nitrocellulose membrane (GE Healthcare) was 
incubated with a goat polyclonal primary antibody 
against haemagglutinin H5 (Cat. No. ab62587, 
Abcam, USA) with the final concentration 1 
µg/µL, for 1 hour. The membrane was developed 
using a commercial kit using the chromogenic 
substance, WesternBreeze (Invitrogen).  
Immunofluorescence antibody test (IFAT) 
was performed using 80% confluent CEFs. Cells 
were either infected with viruses at 0.3 MOI, or 
left uninfected (negative control). The infection 
was left overnight in 2% NBBS DMEM medium, 
before incubation with a rabbit polyclonal primary 
antibody against haemagglutinin H5 (Cat. No. 
ab70077, Abcam, USA) with the final 
concentration 1 µg/µL, for 2 hours. After three 
washes with PBS, cells were incubated with 
fluorescein-labelled secondary antibodies for 1 
hour. Slides were viewed under a fluorescent 
microscope (model Leica DMRA II).  
 
Immunization of animals. One-day old specific 
pathogen-free (SPF) chickens were inoculated 
subcutaneously with 105 plaque forming unit 
(PFU) of parental FWPV FP9 (WT FP9), 
rFWPV/H5 or rFWPV/H5/IL-15, diluted in 
PBS to a total volume of 100 μL, at the scruff of 
the neck, using a 27-G needle. One control group 
was mock-treated with 100 μL of PBS. Nine 
chickens were assigned for each group. Blood 
sampling (for serum) of each chicken was done on 
a weekly basis. At Weeks 2 and 5, whole blood 
(0.2 mL) of each chicken in each group of nine 
was sampled and pooled into 3 groups (0.6 mL in 
total), for CD4+ and CD8+ lymphocyte isolation, 
followed by flow cytometry analysis. As for IL-15 
and IL-18 gene expression analysis, immunization 
of 105 PFU of aforementioned vaccine groups 
was done on 14-days old SPF chickens; twelve 
chickens for each group. At every two consecutive 
days’ post immunization, RNA was extracted 
from the spleens (four from each group) and 
processed for qPCR.  
 
Serological tests. Haemagglutination inhibition 
(HI) tests were performed in U-bottomed 96-well 
microtitre plates using 4 HA units/25 μL of 
H5N2 virus strain A/Malaysia/Duck/8443/04 
(Veterinary Research Institute Ipoh, Malaysia), 
and washed chicken erythrocytes (25 μL of 0.8% 
v/v). The antigen-antibody was incubated for 1 
hour. HI titres were determined as the reciprocal 
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of the highest serum dilution that completely 
inhibited haemagglutination. 
 
Immunophenotyping analysis. Fresh, non-
coagulated chicken whole blood was diluted to 1 
mL using cold PBS and was carefully layered on 2 
mL Ficoll-Paque PLUS (GE Healthcare). 
Isolation of peripheral blood mononuclear cells 
(PBMC) was done by following the standard 
Ficoll-Paque PLUS protocol. Approximately 106 
cells were incubated with mouse anti-chicken 
CD8a-PerCP-Cy5-conjugated (1 µg/mL), CD3-
PE-conjugated (0.5 µg/mL) and CD4-FITC-
conjugated (0.5 µg/mL) monoclonal antibodies 
(all from Southern Biotech), prior to analysis 
using a BD FACSCalibur flow cytometer (Becton 
Dickinson, San Jose, CA, USA). 
 
Quantitative real time polymerase chain 
reaction (qPCR). The total RNA from chicken 
spleens was harvested using TRIzol reagent 
(Ambion) according to manufacturer’s 
recommendations.  The extracted RNA  was 
reverse-transcribed using Script cDNA synthesis 
kit (Jena Bioscience) in a total volume of 20 μL 
containing 2.5 μM primers, 1X Script reverse 
transcriptase (RT) buffer, 500 μM dNTP, 5 μM 
DTT stock, 40 units RNAse inhibitor, 100 units 
Script RT and 5 μg RNA template. The reaction 
mix was incubated at 42oC for 10 minutes 
followed by 50°C for 60 minutes. Primer 
sequences for cytokines IL-15 and IL-18, and a 
housekeeping gene, glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH), were designed from 
public databases (Brisbin et al., 2010; Cai et al., 
2009), as shown in Table 1. The qPCR 
amplification was performed according to the 
KAPA SYBR FAST qPCR kit (KAPA Biosystem) 
using Bio-Rad CFX96 real-time system. The data 
was imported into the analysis module of the Bio-
Rad CFX Manager. The expression of GAPDH 
gene were used as the qPCR normalization 
standards. All results are reported as delta-delta 
CT (ΔΔCT), relative to the control group. 
 
Statistical analysis. Data variations between 
groups were analysed by one-way ANOVA or 
paired-samples T test using SPSS (Version 15) 
software. Results were expressed as the mean ± 
standard error of the mean (SE). P values less than 




Table 1. Forward and reverse primer sequences used for qPCR. 
Primer name Primer sequence (5’ to 3’) GenBank accession number 
IL-15 - F CGAGGCTTGTACCGCAATGT 
AF139097 
IL-15 - R GCCATCCCCAGCATCTTGT 
IL-18 - F ACAAGGAATGTTCTTGGCCTTT 
NM_204608 
IL-18 - R CTTCATCTTCTCTCGGCAGTTTC 
GAPDH - F CTACACACGGACACTTCAAG 
NM_204305 
GAPDH - R ACAAACATGGGGGCATCAG 





PCR amplification of H5 gene. The HPAIV 
haemagglutinin (HA) gene of the H5 virus 
contains multiple basic amino acids, arginine and 
lysine, that allow cleavage by ubiquitous proteases 
(furin and PC6) (Horimoto et al., 1994). To 
maintain compatibility with recombinant, killed 
H5N1 influenza vaccines (J. Wood, personal 
communication), and to reduce any potential 
biosafety issues, the pentabasic peptide motif 
(underlined) at the protease cleavage site of H5, S-
P-Q-R-E-R-R-R-K-K-R was removed and 
replaced with threonine (T), leaving a monobasic 
arginine (R) at the site (S-P-Q-R-E-T-R). The H5-
F and S(1-R) primers generated the first H5 
fragment (1036 bp), while primers H5-R and S(2-
F) generated the second H5 fragment (684 bp). 
Full length mutated H5 gene (1695 bp), was 
obtained through PCR overlap extension 
mutagenesis (Figure 1a). 
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Figure 1. (a) PCR amplification of H5 gene upon removal of polybasic sequence. Lane 1: Negative control; 
Lane 2: Full length HA H5 gene (1707 bp); Lane 3: Fragment 1 (1036 bp) and Lane 4: Fragment 2 (684 
bp) were generated using mutagenic primers S(2-F) and S(1-R); Lane 5: Re-assembled full length H5 
sequence, lacking the polybasic region (1695 bp) was obtained using PCR overlap extension mutagenesis. 
(b) Verification for the integration of the IL-15 gene into rFWPV/H5 by PCR after genomic DNA 
extraction, with exclusive amplicon of 700 bp which corresponds to the positive control. Lanes 1-8: 
Genomic DNA of recombinant clones rFWPV/H5 after second homologous recombination. Lane 9: IL-
15 plasmid positive control. M1: 1 kb ladder marker (New England Biolabs); M2: 100 bp ladder marker 
(New England Biolabs). The DNA bands were observed in 1% (w/v) agarose gel. 
 
 
Verification of H5-recombinant fowlpox 
viruses coexpressing chicken IL-15. Upon 
successful transfection, the recombinant clones 
were verified for presence of the inserted H5 gene 
by PCR of extracted FWPV genomic DNA (data 
not shown). Positive recombinants (rFWPV/H5) 
were subjected to second homologous 
recombination of vector pPC1.X carrying chicken 
cytokine gene IL-15 at a second non-essential site, 
the PC-1 (fpv030) homology region. The cytokine 
expression cassettes in pPC1.X/IL-15 were 
previously confirmed by restriction digests and 
sequencing (data not shown). Screening of 
positive recombinant viruses (rFWPV/H5/IL-
15) was done using primers external and internal 
to the inserted genes (the latter resulting in PCR 
products exclusively for recombinant clones) 
(Figure 1b). H5 protein expression was analysed 
by western blotting (Figure 2). A faint band at ~50 
kD was observed for H5 recombinant, none for 
uninfected cell lysate and negative control (WT 
FP9). This is the first report on the size of H5 
protein from strain A/Ch/Malaysia/5744/2004. 
Further analysis using IFAT detected fluorescent 
signals only for CEF infected with H5 
recombinant, which indicates successful H5 
protein expression. No reactivity was observed 
for uninfected or WT FP9-infected CEF (Figure 
3). 
 
Figure 2. Western blot analysis of CEF cells 
infected with rFWPV/H5. Transferred 
nitrocellulose membrane was incubated with a 
goat polyclonal primary antibody against 
haemagglutinin H5 (Cat. No. ab62587, Abcam, 
USA) with the final concentration 1 µg/µL, for 1 
hour and separated on 12% SDS-PAGE. M: 
BenchmarkTM Pre-stained Protein Ladder 
(Thermo Fisher Scientific); Lane 1: Uninfected 
CEF as negative control; Lane 2: CEF infected 
with WT FP9; Lane 3: CEF infected with 
rFWPV/H5. 
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Figure 3. IFAT analysis for verification of H5 
protein expression from rFWPV/H5. CEFs were 
(A) uninfected; (B) infected with WT FP9 as 
negative control; (C) infected with rFWPV/H5. 
Infected cells were incubated with a rabbit 
polyclonal primary antibody against 
haemagglutinin H5 (Cat. No. ab70077, Abcam, 
USA) with the final concentration 1 µg/µL. 
Observation was performed under visible light (ii) 
or UV light (ii). The images did not represent 80% 
of cell confluency due to repeated washing of the 
cells without fixation during procedure. 
 
Haemagglutinin inhibition tests for chickens 
following rFWPV immunizations. None of the 
nine control chickens inoculated with PBS or WT 
FP9 showed any evidence of HI antibody 
responses. Mean HI titres, in log2, of all groups 
were calculated for general comparison (Table 2). 
H5 antibodies reached detectable levels in 
chickens vaccinated with rFWPV/H5/IL-15 one 
week earlier than those vaccinated with 
rFWPV/H5 but, thereafter, there was no 
significant difference between the two groups. 
Responses were highest at Week 3 in both groups 
of recombinant vaccine-treated chickens. 
However, the antibodies were undetectable based 
on HI tests that have been carried out from Week 
5 onwards.  
 
CD3+/CD4+ and CD3+/CD8+ T cells 
population following rFWPV immunizations. 
The levels of CD3+/CD4+ T cells in the control 
group remained relatively constant at Weeks 2 and 
5. Samples from groups vaccinated with WT FP9 
or rFWPV/H5/IL-15 demonstrated increases in 
CD3+/CD4+ T cell population levels over time, 
of 2.06 and 3.16 point percentages, respectively. 
The rFWPV/H5 vaccinated group showed a 
significantly higher CD3+/CD4+ T cell 
population relative to control at Week 2 (P≤0.05) 
but had returned to control levels by Week 5. No 
statistically significant difference in CD3+/CD4+ 
T cell levels was observed for other groups at 
either sampling point (Figure 4). 
Animal experiments also revealed a relatively 
constant CD3+/CD8+ T cell population for 
control chickens. The same was true for the slight 
to somewhat higher levels observed in 
rFWPV/H5/IL-15-, WT FP9- and rFWPV-
vaccinated birds (significant for WT- and 
rFWPV/H5- but not rFWPV/H5/IL-15-
vaccinated birds), although a fall to control levels 





Table 2. Mean of HI titre, log2, of sera from immunized chickens. 
Vaccine group 
HI titre 
Weeks, post immunization 
1 2 3 4 5 6 7 
Control ND ND ND ND ND ND ND 
WT FP9 ND ND ND ND ND ND ND 
rFWPV/H5 ND ND 8.11±4.60 3.56±1.94 ND ND ND 
rFWPV/H5/IL-15 ND 0.56±0.44 9.89±2.16 3.11±1.74 ND ND ND 
ND indicates undetected titre. Each value represents the means±SE of nine birds.  
No significant difference was observed between rFWPV/H5 and rFWPV/H5/IL-15 at any time point (P≥0.05). 
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Figure 4. Immunophenotyping of CD3+/CD4 
(a) and CD3+/CD8+ (b) lymphocytes from 
chickens after mock-treatment with PBS 
(control), or vaccination with WT FP9, 
rFWPV/H5 or rFWPV/H5/IL-15. Each value 
represents the mean percentages of T 
lymphocytes sub-population ± SE, from PBMC 
samples of nine chickens pooled in threes (n=3), 
sampled at Weeks 2 and 5. Significant differences 
between vaccinated and control groups (*), were 
determined by one-way ANOVA (P≤0.05). 
Significant differences within the same group at 
different points were determined by paired-
samples T-test (P≤0.05). 
 
 
Gene expression analysis of IL-15 and IL-18. 
IL-15 expression in all vaccinated groups showed 
upregulation on day 2, notably in those vaccinated 
with rFWPV/H5/IL-15, which overexpress 
chicken IL-15 (Figure 5). WT FP9- and 
rFWPV/H5-vaccinated birds expressed 7- to 19-
fold more IL-15 than control birds; over-
expression by rFWPV/H5/IL-15 boosted IL-15 
levels to 120 fold more than control. Expression 
of IL-15 dropped to control levels by day 4, for all 
tested groups. 
IL-18 expression was lower in all of the 
FWPV-infected groups (two to five fold lower for 
WT FP9- and rFWPV/H5-vaccinated groups, 
possibly up to ten fold lower for rFWPV/H5/IL-
15) and this decreased expression was extended 
out to 6 days. 
 
 
Figure 5. Relative expression level, by qPCR, of 
IL-15 (a) and IL-18 genes (b) in inoculated SPF 
chickens compared to control SPF chickens. The 
expression was expressed as fold change (2 log -
∆∆CT) to that of the unvaccinated controls after 
normalization of expression to GAPDH. The 
standard errors were calculated from the result of 
three replicates. Significant differences between 
vaccinated groups and WT FP9 (*) were 






The most important component of host immune 
response that confers protection in chickens 
against AIV is the humoral response against HA 
(Swayne, 2007). To achieve this, several different 
types of vaccines have been developed, e.g. 
inactivated AIV vaccines (Bublot et al., 2007; Tian 
et al., 2010), DNA vaccines (Lim et al., 2012), and 
virus-like particles (Hendin et al., 2017). In this 
study, a safe, lab-adapted FWPV-based vector 
expressing the H5 of AIV was modified to co-
express a chicken IL-15 cytokine gene to test if it 
would enhance the host cell mediated immune 
response, which may be critical in clearance of 
AIV during infection (Foong et al., 2009). 
However, we did not perform protective or 
challenge studies for AIV, nor did we evaluate 
protection against FWPV. 
Vaccination with rFWPV/H5/IL-15 
produced HA antibody titres comparable to 
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vaccination with rFWPV/H5. This finding 
contrasts with several studies conducted in mice, 
including that by Perera et al. (2007) which 
reported induction of two-fold higher VACV-
neutralizing antibody titres in hIL-15-expressing 
recombinant VACV. The group also showed that 
recombinant VACV strain Wyeth, expressing five 
heterologous influenza virus genes, induced 
stronger neutralizing antibodies against AIV H5 
when adjuvanted with hIL-15 (Poon et al., 2009). 
The inconsistencies in HA antibody titres 
between our study and those by Perera et al. (2007) 
and Poon et al. (2009) might be due to the usage 
of heterologous (instead of a homologous) H5N2 
virus strain A/Malaysia/Duck/8443/04 antigens 
against the H5 antibodies from our rFWPV 
recombinants. Heterologous antigens used to 
assay H5 antibodies induced by rFWPV were 
shown to produce either low (Taylor et al., 1988), 
highest (Bublot et al., 2010) or inconsistent 
(Swayne et al., 2007) HI titres.  Although these 
studies did not use homologous antigens, which 
might be more suitable for their HI testing, the 
results provide useful comparisons of HI 
antibody levels elicited by rFWPV/H5 and 
rFWPV/H5/IL-15. Several studies have shown 
rFWPV expressing H5 can provide complete or 
nearly complete protection against lethal 
challenge, even when achieving pre-challenge HI 
titres of as low as 3 log2 (Bublot et al., 2010; 
Webster et al., 1991). Post-vaccination protection 
of chickens against AIV may not be dependent 
entirely on HI antibodies but also on non-HI 
antibodies and possibly also on cell-mediated 
immunity. 
rFWPV/H5/IL-15 did not increase CD4+ T 
cell populations, compared to rFWPV/H5, 
following vaccination. This finding is consistent 
with previous reports that IL-15 only has 
profound effects on the proliferation and survival 
of memory CD8+ T cells, not on CD4+ T cells 
(Marks-Konczalik et al., 2000; Zhang et al., 1998), 
although a significant increment of CD4+ T cell 
populations was observed in a DNA vaccine 
coexpressing H5 and chicken IL-15 genes (Lim et 
al., 2012). It is not known whether inherent 
molecular patterns of, or immunomodulatory 
proteins expressed by, FWPV FP9 can influence 
IL-15 levels in vaccinated chickens. It has been 
reported that IL-15 can only activate CD4+ T cell 
proliferation when at high concentration presence 
(Kanegane and Tosato, 1996). Niedbala et al. 
(2002) showed that 2 to 4 fold higher 
concentrations of IL-15 are required to achieve 
optimal CD4+ T cell proliferation than to 
promote CD8+ T cell response. 
The co-stimulatory effects of IL-15 on CD8 
cells have been studied widely, especially with 
regard to proliferation and survival of memory 
CD8+ T cells.  IL-15 has been found to directly 
stimulate purified CD8+ memory cells in vitro 
(Zhang et al., 1998). Transgenic mice which 
constitutively expressed a significant level of IL-
15 in the serum had higher numbers of memory 
CD8+ T cells (Marks-Konczalik et al., 2000; 
Yajima et al., 2002). In our study, chickens 
vaccinated with WT FP9 or rFWPVs showed low 
to moderate increase in levels of CD8+ T cells. 
The increases, at 1.6 to 2 fold, were significant for 
WT FP9 or rFWPV/H5 respectively but, at 1.25 
fold increment, was insignificant from the 
rFWPV/H5/IL-15. These results suggest that 
FWPV enhances chicken CD8+ T cells 
stimulation and possibly that IL-15 has the 
opposite effect. 
Although hIL-15 has been shown to stimulate 
CD8+ T cells population and promote the 
maintenance of CD8+ CD44hi memory T cells, 
the responsiveness of CD8+ T cells to IL-15 
might depend on the cytokine background 
(Niedbala et al., 2002; Oh et al., 2003). 
Unfortunately, in this study, we did not measure 
the levels of IL-15, secreted by cells infected with 
an initial dose of 105 PFU rFWPV/H5/IL-15, in 
peripheral blood prior to flow analysis. Since a 
strong synthetic/hybrid promoter was used for 
IL-15 co-expression, levels of expression might 
have been inconsistent with generation of the 
desired immune responses. 
We observed elevation of the CD4+ T cell 
population and sustained CD8+ T cell population 
from WT FP9 and rFWPV/H5/IL-15 inoculated 
groups. However, rFWPV/H5 inoculated group 
showed a consistent decreasing pattern for both 
T cells. By way of comparison, an in vivo study 
examining T cell populations in the peripheral 
blood of rhesus macaques treated with rhesus IL-
15, where the level of CD4+ and CD8+ memory, 
but not naïve, T cells peaked at Weeks 1 to 2 and 
returned to baseline by Weeks 3 to 4 (Picker et al., 
2006). 
Acting synergistically, IL-15 and IL-18 can 
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perpetuate Th1 responses (Gracie et al., 1999) and 
enhance IL-12 stimulation of NK cell to produce 
IFN gamma (French et al., 2006). A DNA vaccine 
co-expressing H5 and chicken IL-15, induced a 
significant increase in IL-15, but not IL-18, levels 
post-vaccination (Lim et al., 2012). Our results are 
comparable, where enhanced expression of host 
IL-15 and reduced expression of host IL-18 are 
mediated directly by infection with WT FP9 or 
rFWPV/H5 co-expressing exogenous IL-15 
(mediated by a strong synthetic poxvirus 
promoter). 
The dramatic drop of IL-15 levels from day 2 
to day 4 in all FWPV-infected groups might be 
due to clearance of these attenuated viruses by 
NK cells, their cytolytic activity potentially 
augmented by the ability of IL-15 (expressed 
endogenously by the host or exogenously by the 
recombinant FWPV) to enhance IFN expression 
and increase poxvirus clearance (Foong et al., 
2009). However, we cannot currently explain the 
concomitant drop in IL-18 mRNA expression 
during FWPV infection but FWPV appears to 
express one or more IL-18 binding proteins 
(Laidlaw and Skinner, 2004), which might reduce 
steady-state levels of circulating IL-18 in a similar 
manner to the host-encoded regulator IL-18BP 
(Harms et al., 2017). It is possible therefore that 
the virus encodes additional mechanisms to 






rFWPV/H5 and rFWPV/H5/IL-15 inoculated 
groups elicited the highest levels of anti-H5 
antibodies at Week 3 post-inoculation. 
CD3+/CD4+ or CD3+/CD8+ T cell 
populations were significantly increased in both 
WT FP9- and rFWPV/H5-, higher than in 
rFWPV/H5/IL-15-vaccinated chickens, at Week 
2 post-inoculation. IL-15 and IL-18 expressions 
were upregulated in all vaccinated groups at day 2 
post-inoculation. These diverse immunogenicity 
findings may contribute to the limited exploration 
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